Evidence map›Paper›PMID 34092923›Full record

ArticleSensors and actuators. B, Chemical2021

A bistable, multiport valve enables microformulators creating microclinical analyzers that reveal aberrant glutamate metabolism in astrocytes derived from a tuberous sclerosis patient.

Dusty R Miller, David K Schaffer, M Diana Neely, Ethan S McClain, Adam R Travis, Frank E Block, Jennifer Mckenzie, Erik M Werner, Laura Armstrong, Dmitry A Markov and 4 more

Open access · greenAbstract read
In one paragraph

Article in Sensors and actuators. B, Chemical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Dusty R MillerDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, U.S.A.
David K SchafferVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, TN 37235, U.S.A.
M Diana NeelyDepartment of Pediatrics, Vanderbilt University Medical Center, 1211 Medical Center Dr., Nashville, TN 37232, U.S.A.
Ethan S McClainDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, U.S.A.
Adam R TravisDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, U.S.A.
Frank E BlockDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235, U.S.A.
Jennifer MckenzieDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, U.S.A.
Erik M WernerVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, TN 37235, U.S.A.
Laura ArmstrongDepartment of Pediatrics, Vanderbilt University Medical Center, 1211 Medical Center Dr., Nashville, TN 37232, U.S.A.
Dmitry A MarkovVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, TN 37235, U.S.A.
Aaron B BowmanVanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37232, U.S.A.
Kevin C EssDepartment of Pediatrics, Vanderbilt University Medical Center, 1211 Medical Center Dr., Nashville, TN 37232, U.S.A.
David E CliffelDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, U.S.A.
John P WikswoVanderbilt Institute for Integrative Biosystems Research and Education, Vanderbilt University, Nashville, TN 37235, U.S.A.
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
Mechanisms of Methylmercury Induced Neuron ToxicityR01ES007331 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 1996 to 2026
$10.6M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanomaU01TR002383 · NCATS · VANDERBILT UNIVERSITY · PI MURPHY, WILLIAM L., TAYLOR, D. LANSING · 2018 to 2022
$7.6M
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological modelsUH3TR002097 · NCATS · VANDERBILT UNIVERSITY · PI ESS, KEVIN C, NEELY, MAJA DIANA · 2019 to 2021
$4.6M
Gene-Neurotoxicant Interactions in Huntington DiseaseR01ES016931 · NIEHS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOWMAN, AARON B · 2008 to 2018
$4.5M
Physical Dynamics of Cancer Response to Chemotherapy in 3D MicroenvironmentsU01CA202229 · NCI · VANDERBILT UNIVERSITY · PI MARKOV, DMITRY, MCCAWLEY, LISA JOY · 2015 to 2019
$3.0M
Instrumenting the Fetal Membrane on a ChipR01HD102752 · NICHD · VANDERBILT UNIVERSITY · PI CLIFFEL, DAVID E · 2020 to 2023
$2.5M
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological modelsUG3TR002097 · NCATS · VANDERBILT UNIVERSITY · PI BOWMAN, AARON B, ESS, KEVIN C · 2017 to 2018
$2.5M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)TL1TR000447 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$1.2M
NCATS NIH HHS TL1 TR000447NCATS NIH HHS U01 TR002383NCATS NIH HHS UG3 TR002097NCATS NIH HHS UH3 TR002097NCATS NIH HHS UL1 TR002243NCI NIH HHS U01 CA202229NICHD NIH HHS P50 HD103537NICHD NIH HHS R01 HD102752NIEHS NIH HHS R01 ES007331NIEHS NIH HHS R01 ES010563NIEHS NIH HHS R01 ES016931NIEHS NIH HHS T32 ES007028
6 · The paper itself

Abstract

There is a need for valves and pumps that operate at the microscale with precision and accuracy, are versatile in their application, and are easily fabricated. To that end, we developed a new rotary planar multiport valve to faithfully select solutions (contamination = 5.22 ± 0.06 ppb) and a rotary planar peristaltic pump to precisely control fluid delivery (flow rate = 2.4 ± 1.7 to 890 ± 77 μL/min). Both the valve and pump were implemented in a planar format amenable to single-layer soft lithographic fabrication. These planar microfluidics were actuated by a rotary motor controlled remotely by custom software. Together, these two devices constitute an innovative microformulator that was used to prepare precise, high-fidelity mixtures of up to five solutions (deviation from prescribed mixture = ±|0.02 ± 0.02| %). This system weighed less than a kilogram, occupied around 500 cm

Indexed as

electrochemistrymicroclinical analyzersoft lithographytime-division multiplexingTuberous sclerosis complex (TSC)

Identifiers

PMID34092923
PMCPMC8174775
OpenAlexW3154802185

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.